Summary
Inflammatory Response In Major Injury & Recombinant Human Erythropoietin (IRMINE pilot study) ISCRTN Registration
This is a randomised, blinded, single centre placebo-controlled pilot trial to evaluate the feasibility of conducting a larger scale, multi-centre trial to evaluate the impact of administering recombinant human erythropoietin (rhEPO) on adults who have experienced severe trauma and been admitted to an Intensive Therapy Unit (ITU) compared with those administered saline as a placebo.
ISCRTN: ISCRTN Page
REC reference: 15/WA/0361
Contact Details
Trial Manager / Lead Contact: Dr Kym Carter
Phone: 01792 606372
Email: k.carter@swansea.ac.uk
Website: https://www.swansea.ac.uk/staff/medicine-health-life-science/medicine/health-data-science/carter-k/
ISCRTN Number: 40935649; Eudra CT Number: 2015-002255-10;